⌘K

Login Start Free

Home/Filings/4/0001104659-23-107491

4//SEC Filing

NAGEL MICHAEL 4

Accession 0001104659-23-107491

CIK 0001792581other

View on SEC.gov Company Profile

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 4:07 PM ET

Size

5.5 KB

Accession

0001104659-23-107491

Insider Transaction Report

Form 4

Period: 2023-10-05

Kiromic Biopharma, Inc.KRBP

Director

Transactions

Award
Restricted Stock Units
2023-10-05+18,000→ 18,000 total
From: 2023-10-05→ Common Stock (18,000 underlying)

Footnotes (1)

[F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU.

Documents

1 file

4
tm2327977-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Kiromic Biopharma, Inc.

CIK 0001792581

Entity typeother

Related Parties

1

filerCIK 0001213863

Filing Metadata

Form type: 4
Filed: Oct 5, 8:00 PM ET
Accepted: Oct 6, 4:07 PM ET
Size: 5.5 KB

View on SEC.gov